Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer.

Cancers (Basel) · 2016 · PMC4931621 · PMID 27322324

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In addition, we experimentally confirmed the results of several database searches indicating highly significant overexpression of α-lactalbumin in human triple negative breast cancer (TNBC) [ 4 , 5 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.